AstraZeneca CEO visits White House to formalize MFN agreement with Trump
President Donald Trump has been pressuring top drugmakers to get on board with his drug pricing agenda for months. Now, AstraZeneca is ready to comply.
Swiss auto-injector specialist Ypsomed invests $248M to build manufacturing facility in N.C.
Auto-injector specialist Ypsomed is hopping on the United States manufacturing bandwagon, investing 200 million Swiss francs ($248 million) to build a plant in Holly Springs, North Carolina. It will be the first
Rebuilding Gaza: don’t sideline Palestinian scientists, say experts
Nature, Published online: 10 October 2025; doi:10.1038/d41586-025-03324-w Researchers warn against ‘top down’ solutions as ceasefire is agreed in the first phase of a peace deal.
Portable muon beam could accelerate archaeology scans
Nature, Published online: 10 October 2025; doi:10.1038/d41586-025-03245-8 Laser plasma device could be light enough to be used on the field.
Future solitude
Nature, Published online: 10 October 2025; doi:10.1038/d41586-025-03251-w Alone but not lonely.
AstraZeneca kicks off construction of $4.5B API plant in Virginia
AstraZeneca has broken ground on a $4.5 billion manufacturing facility near Charlottesville, Virginia, confirming a report about its location six weeks ago when state lawmakers approved an economic development package for the
Lupin rides the onshoring wave, pledging $250M to build new respiratory production plant in Fla.
Lupin expects to invest a combined $250 million—covering R&D, infrastructure and capital expenditures over five years—to build a new pharmaceutical production plant in Coral Springs, Florida. The site will focus on the
OXB kicks off US expansion, buying viral vector plant in N.C. from National Resilience for $4.5M
Less than two months after OXB revealed a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy manufacturer has purchased a viral vector plant in North Carolina
Eli Lilly earmarks $1B-plus for contract manufacturing partnerships in India
The company will work with new local contract manufacturers in India to boost supply of its key medicines.
FDA launches generics pilot program, advances facility PreCheck proposal in bid to incentivize US drug manufacturing
The FDA unveiled a new pilot program that aims to speed up review times for generic drugmakers who test and manufacture their products in the U.S. Separately, the agency met with industry